NO20055144L - Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr. - Google Patents

Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr.

Info

Publication number
NO20055144L
NO20055144L NO20055144A NO20055144A NO20055144L NO 20055144 L NO20055144 L NO 20055144L NO 20055144 A NO20055144 A NO 20055144A NO 20055144 A NO20055144 A NO 20055144A NO 20055144 L NO20055144 L NO 20055144L
Authority
NO
Norway
Prior art keywords
cattle
treatment
parasitic infections
microbial
animals
Prior art date
Application number
NO20055144A
Other languages
English (en)
Inventor
Dale E Shuster
David G Sawutz
Kanwal J Varma
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of NO20055144L publication Critical patent/NO20055144L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Formulering som kombinerer en antiparasittisk forbindelse, så som et avermektin, med et antibiotisk, fluorert kloramfenikol- eller tiamfenikolderivat, så som Florfenikol. Det beskrives også anvendelse av slike formuleringer ved behandling og forhindring av infeksjonssykdommer hos storfe og svin, iimbefattende bovin respirasjonssykdom og parasittiske infeksjoner.
NO20055144A 2003-04-03 2005-11-02 Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr. NO20055144L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46012603P 2003-04-03 2003-04-03
PCT/US2004/010143 WO2004089355A2 (en) 2003-04-03 2004-04-01 Compositions for treating microbial and parasitic infections in cattle and other animals

Publications (1)

Publication Number Publication Date
NO20055144L true NO20055144L (no) 2005-11-02

Family

ID=33159732

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055144A NO20055144L (no) 2003-04-03 2005-11-02 Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr.

Country Status (22)

Country Link
US (1) US20040198704A1 (no)
EP (1) EP1608356A2 (no)
JP (1) JP2006522147A (no)
KR (1) KR20060021821A (no)
CN (1) CN1767822A (no)
AR (1) AR043824A1 (no)
AU (1) AU2004227997A1 (no)
BR (1) BRPI0419273A (no)
CA (1) CA2519380A1 (no)
CL (1) CL2004000710A1 (no)
EC (1) ECSP056074A (no)
HK (1) HK1080366A1 (no)
MX (1) MXPA05010693A (no)
NO (1) NO20055144L (no)
NZ (1) NZ542379A (no)
PE (1) PE20050099A1 (no)
PL (1) PL378820A1 (no)
RU (1) RU2359667C2 (no)
TW (1) TW200503682A (no)
UA (1) UA82359C2 (no)
WO (1) WO2004089355A2 (no)
ZA (1) ZA200507857B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050386A1 (es) * 2003-05-29 2005-06-23 Schering Plough Ltd Composiciones farmaceuticas de florfenicol
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
GB0501220D0 (en) * 2005-01-21 2005-03-02 Norbrook Lab Ltd Anthelmintic composition
BRPI0608562B1 (pt) * 2005-02-24 2015-09-08 Syngenta Ltd método para controlar dano de um material por peste, composição e cápsula
WO2008076256A1 (en) 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
EP2222168B1 (en) * 2007-11-26 2018-09-12 Merial, Inc. Solvent systems for pour-on formulations for combating parasites
PE20091171A1 (es) * 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol
CN102131772B (zh) 2008-07-30 2015-03-11 英特威国际有限公司 用作氟苯尼考的中间体的*唑啉-保护的氨基二醇化合物的制备方法
KR101473979B1 (ko) * 2013-01-18 2014-12-26 한국썸벧(주) 마보플록사신을 포함하는 약제학적 조성물
RU2641962C2 (ru) * 2013-07-03 2018-01-23 С.П. Ветеринариа, С.А. Инъецируемая ветеринарная композиция
EP3023092A1 (en) * 2014-11-20 2016-05-25 Ceva Sante Animale Eprinomectin parenteral compositions
RU2649809C2 (ru) * 2015-03-03 2018-04-04 Общество с ограниченной ответственностью "Научно-внедренческий центр "Агроветзащита" Жидкая гомогенная фаза для трансдермальных фармацевтических композиций
CN105079000B (zh) * 2015-09-22 2018-07-06 佛山市南海东方澳龙制药有限公司 一种组合物及其应用、制剂
CN105796488A (zh) * 2016-03-23 2016-07-27 张先碧 一种氟苯尼考溶液制剂及其制备方法
US9943387B2 (en) 2016-06-29 2018-04-17 International Business Machines Corporation Unmanned aerial vehicle-based system for livestock parasite amelioration
KR102647267B1 (ko) * 2021-06-29 2024-03-18 대한뉴팜(주) 툴라스로마이신과 톨페남산의 복합 주사제 제제

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal
US6174540B1 (en) * 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
BR0209241A (pt) * 2001-04-27 2004-06-15 Pfizer Prod Inc Processo para preparação de derivados de9-deoxo-9a-aza-9a-homoeritromicina a 4-substituida
US20030068339A1 (en) * 2001-10-02 2003-04-10 Phoenix Scientific, Inc. Veterinary florfenicol formulation that is syringeable under cold weather conditions
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
NZ520295A (en) * 2002-07-19 2005-04-29 Ashmont Holdings Ltd Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin
US6653288B1 (en) * 2002-09-30 2003-11-25 Virbac S.A. Injectable anthelmintic compositions and methods for using same
US20040091579A1 (en) * 2002-11-13 2004-05-13 Rubicon Scientific Llc; Extruded foodstuffs having maintenance level actives
PE20050386A1 (es) * 2003-05-29 2005-06-23 Schering Plough Ltd Composiciones farmaceuticas de florfenicol

Also Published As

Publication number Publication date
TW200503682A (en) 2005-02-01
CA2519380A1 (en) 2004-10-21
WO2004089355A3 (en) 2005-01-20
AU2004227997A1 (en) 2004-10-21
ZA200507857B (en) 2007-04-25
KR20060021821A (ko) 2006-03-08
RU2005133875A (ru) 2006-03-20
US20040198704A1 (en) 2004-10-07
RU2359667C2 (ru) 2009-06-27
NZ542379A (en) 2009-01-31
EP1608356A2 (en) 2005-12-28
PL378820A1 (pl) 2006-05-29
HK1080366A1 (zh) 2006-04-28
WO2004089355A8 (en) 2005-11-03
CL2004000710A1 (es) 2005-05-27
JP2006522147A (ja) 2006-09-28
MXPA05010693A (es) 2005-12-12
ECSP056074A (es) 2006-03-01
PE20050099A1 (es) 2005-02-28
CN1767822A (zh) 2006-05-03
WO2004089355A2 (en) 2004-10-21
UA82359C2 (uk) 2008-04-10
BRPI0419273A (pt) 2008-07-15
AR043824A1 (es) 2005-08-17

Similar Documents

Publication Publication Date Title
NO20055144L (no) Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr.
UA81676C2 (ru) Композиция для лечения инфекций у крупного рогатого скота и свиней
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
UA81629C2 (ru) Применение композиции и способ лечения инфекционных заболеваний крупного рогатого скота и свиней
NO20052306L (no) Dispergerbare farmasoytiske blandinger.
EA200700202A1 (ru) Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей
BRPI0416796A (pt) compostos orgánicos
DK1412384T3 (da) Stabil formulering af modificeret GLP-1
BR0313148A (pt) Formulações de liberação controlada compreendendo lamotrigina
SV2002000245A (es) Oxazolidinonas substituidas y su uso ref. lea 34122-sv
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
CY1107480T1 (el) Χρηση aivlosin για την θepαπευτικη αγωγη και προληψη λοιμωξεων lawsonia σε χοιρους
ATE453646T1 (de) 3-substituierte n-(aryl- oder heteroaryl)pyrazoä1,5-aüpyrimidine als kinaseinhibitoren
ITFI20030058A1 (it) Formulazioni farmaceutiche contenenti tiazolidinedioni
DK1228758T3 (da) Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom
CY1114480T1 (el) Συνθεσεις που περιλαμβανουν διαχωρισμενο αγωνιστη υποδοχεα γλυκοκορτικοειδους για τη θεραπεια ή τον ελεγχο φλεγμονης προσθιου τμηματος
BRPI0416376A (pt) composições para a redução da colonização bacteriana e da invasão do snc e métodos de uso destes
BRPI0407368A (pt) tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas.
AR066372A1 (es) Formulaciones de aminoacidos n-halogenados con compuestos antiinflamatorios
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
AU2001228513A1 (en) Stabilised pharmaceutical compositions and process for their preparation comprising an antibiotic and an expectorant
WO2006012146A3 (en) Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
WO2011009771A3 (en) Immunogenic and therapeutic compositions for streptococcus suis
BRPI0414223A (pt) uso de extratos de gentiana lutea como um agente antimicrobiano
EA200401523A1 (ru) Способы применения и композиции для диагностики и лечения инфекционного заболевания

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application